These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 35410603)

  • 1. What is the Role of Lithium in Epilepsy?
    Bojja SL; Singh N; Kolathur KK; Rao CM
    Curr Neuropharmacol; 2022; 20(10):1850-1864. PubMed ID: 35410603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders.
    Forlenza OV; De-Paula VJ; Diniz BS
    ACS Chem Neurosci; 2014 Jun; 5(6):443-50. PubMed ID: 24766396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A systematic analysis of neurobiological roles of lithium].
    Gogoleva IV; Gromova OA; Torshin IY; Grishina TR; Pronin AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11):17-23. PubMed ID: 36440772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium posttreatment confers neuroprotection through glycogen synthase kinase-3β inhibition in intracerebral hemorrhage rats.
    Zheng J; Liu Z; Li W; Tang J; Zhang D; Tang X
    J Neurosurg; 2017 Oct; 127(4):716-724. PubMed ID: 27739937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium and neuropsychiatric therapeutics: neuroplasticity via glycogen synthase kinase-3beta, beta-catenin, and neurotrophin cascades.
    Wada A
    J Pharmacol Sci; 2009 May; 110(1):14-28. PubMed ID: 19423950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium Pharmacology and a Potential Role of Lithium on Methamphetamine Abuse and Dependence.
    Kitanaka N; Hall FS; Uhl GR; Kitanaka J
    Curr Drug Res Rev; 2019; 11(2):85-91. PubMed ID: 31875781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.
    Rybakowski JK
    CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular actions and clinical pharmacogenetics of lithium therapy.
    Can A; Schulze TG; Gould TD
    Pharmacol Biochem Behav; 2014 Aug; 123():3-16. PubMed ID: 24534415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms.
    Won E; Kim YK
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29232923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection.
    Li X; Bijur GN; Jope RS
    Bipolar Disord; 2002 Apr; 4(2):137-44. PubMed ID: 12071511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lithium in the psychopharmacology of affective disorders and mechanisms of its effects on cellular physiology].
    Losenkov IS; Plotnikov EV; Epimakhova EV; Bokhan NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(11):108-115. PubMed ID: 33340305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium down-regulates tau in cultured cortical neurons: a possible mechanism of neuroprotection.
    Rametti A; Esclaire F; Yardin C; Cogné N; Terro F
    Neurosci Lett; 2008 Mar; 434(1):93-8. PubMed ID: 18289787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new avenue for lithium: intervention in traumatic brain injury.
    Leeds PR; Yu F; Wang Z; Chiu CT; Zhang Y; Leng Y; Linares GR; Chuang DM
    ACS Chem Neurosci; 2014 Jun; 5(6):422-33. PubMed ID: 24697257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness.
    Manji HK; Moore GJ; Chen G
    J Clin Psychiatry; 2000; 61 Suppl 9():82-96. PubMed ID: 10826666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis.
    Machado-Vieira R; Manji HK; Zarate CA
    Bipolar Disord; 2009 Jun; 11 Suppl 2(Suppl 2):92-109. PubMed ID: 19538689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of GSK-3 in treatment-resistant depression and links with the pharmacological effects of lithium and ketamine: A review of the literature.
    Costemale-Lacoste JF; Guilloux JP; Gaillard R
    Encephale; 2016 Apr; 42(2):156-64. PubMed ID: 26995153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycogen synthase kinase-3β activity and cognitive functioning in patients with bipolar I disorder.
    Munkholm K; Miskowiak KW; Jacoby AS; Vinberg M; Leme Talib L; Gattaz WF; Kessing LV
    Eur Neuropsychopharmacol; 2018 Mar; 28(3):361-368. PubMed ID: 29433844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen synthase kinase 3beta as a likely target for the action of lithium on circadian clocks.
    Padiath QS; Paranjpe D; Jain S; Sharma VK
    Chronobiol Int; 2004 Jan; 21(1):43-55. PubMed ID: 15129823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based design leads to the identification of lithium mimetics that block mania-like effects in rodents. possible new GSK-3beta therapies for bipolar disorders.
    Kozikowski AP; Gaisina IN; Yuan H; Petukhov PA; Blond SY; Fedolak A; Caldarone B; McGonigle P
    J Am Chem Soc; 2007 Jul; 129(26):8328-32. PubMed ID: 17552518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium in neuropsychiatry: a 2010 update.
    Rybakowski JK
    World J Biol Psychiatry; 2011 Aug; 12(5):340-8. PubMed ID: 21361856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.